All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2011-002739-24 | Does the GLP-1 receptor agonist (Victoza®) improve the metabolic response to physical training in patients with type 2 diabetes? | 2013-12-31 | due-trials |
Reported results | 2012-001371-37 | The impact of liraglutide on glucose tolerance and the risk of type 2 diabetes in women with previous gestational diabetes mellitus Effekten af liraglutide på glukosetolerancen og risikoen for type... | 2019-09-02 | due-trials |
Reported results | 2017-000204-15 | Glimepiride monotherapy vs. combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes Glimepiridbehandling vs. kombinationsbehandling med glimepirid og linagliptin i patie... | 2019-04-26 | due-trials |